The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 6th 2025
A rehabilitation method commonly used in patients who experience a traumatic brain injury was found to improve symptoms of long COVID, including brain fog and measures of daily living.
NCPA Offers Senate Committee Prescriptions for Addressing the Opioid Crisis
October 6th 2017The National Community Pharmacists Association (NCPA) shared with Congress eight recommendations for leveraging independent community pharmacists' knowledge and proximity to patients to help address the opioid crisis.
Read More
Bictegravir Combo Treatment Non-inferior to Boosted Protease Inhibitors in HIV?
October 5th 2017A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.
Read More
Patients Want to Interact with Their Pharmacists on Social Media
October 5th 2017Social media has become a crucial tool for organizations and businesses to interact with their customers and discuss the services they offer. Many Americans look to social media for recommendations and to build stronger relationships with the brands they use.
Read More
FDA OKs Third Indication for BOTOX Cosmetic
October 4th 2017FDA officials have approved onabotulinumtoxinA (BOTOX Cosmetic, Allergan) for its third indication for the temporary improvement in the appearance of moderate-to-severe forehead lines associated with frontalis muscle activity in adults.
Read More
FDA Officials Warn About Compounding Risk
October 4th 2017According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV).
Read More
More Than One-Third of Older Adults Use Sleep Medications
October 3rd 2017Most older adults don’t talk to their health care provider about sleep difficulties, even though more than one-third reported using some type of medication to help them sleep at night, according to results from the National Poll on Healthy Aging.
Read More
Pharmacy Times Takes to Social Media to #ThankAPharmacist During American Pharmacists Month
October 3rd 2017Each October, APhM encourages consumers to “Know Your Medicine, Know Your Pharmacist,” highlighting the important role pharmacists play as they offer assistance with prescription and over-the-counter medication choices.
Read More
ASHP to Create Pharmacy Technician Forum
October 3rd 2017On September 29, 2017, the ASHP (American Society of Health-System Pharmacists) Board of Directors voted unanimously to approve the creation of an enhanced membership home for pharmacy technicians — the ASHP Pharmacy Technician Forum.
Read More
Merck Discontinues 2 HCV Clinical Programs
September 30th 2017This decision was made based on a review of available phase 2 efficacy data and in consideration of the evolving marketplace and the growing number of treatment options available for patients with chronic HCV infection, including elbasvir and grazoprevir (Zepatier).
Read More
New Search Tool Enables Better Access to Adverse Drug Reaction Information
September 29th 2017While the FAERS dashboard now offers stakeholders many more ways of searching for and organizing data on adverse events reported to the FDA for many drug and biologic products, there remain limitations to the data.
Read More
Study Finds Medicare 'DIR Fee' Legislation Would Save Government Billions
September 29th 2017Eliminating retroactive pharmacy payment reductions — or post point-of-sale pharmacy "DIR fees" — in Medicare Part D would save the federal government $3.4 billion over 10 years, according to a Wakely Consulting Group study released today by the National Community Pharmacists Association.
Read More